Submission to first decision (The average time from manuscript submission to desk rejection, direct rejection/acceptance or assignment to the first editor)
Note: For manuscripts that fully comply with the journal template. However, this timeframe does not apply to manuscripts with formatting or guideline deficiencies. If a manuscript is returned to the authors for corrections, the administrative review process will restart from the re-submission date.
3 weeks
Submission to decision after review (For papers that are sent to review, the average time from submission to receipt of first editor decision) 6 weeks
Submission to final decision (The average time from manuscript submission to the final editorial decision) 16 weeks
Submission to publication (The average time from acceptance to publication. Manuscript published in early view are also included in this calculation) 24 weeks

ACTA Pharmaceutica Sciencia 2010 , Vol 52 , Num 2
EXACERBATED CARDIAC INJURY INDUCED BY RENAL ISCHEMIA/REPERFUSION IN DIABETES MELLITUS-II
JİTENDRA VAGHASİYA, NAVİN SHETH, YAGNİK BHALODİA
Department of Pharmacology, Smt. RBPMPC, Atkot - Rajkot, Gujarat, India Viewed : 18124 - Downloaded : 5677 The present work was designed to investigate the role of Diabetes Mellitus Type-II (DM-II) on renal ischemia reperfusion (I/R)-associated pathophysiology in cardiac damage. DM-II in rats was induced by the administration of nicotinamide (230 mg/kg, i.p.) and streptozotocin (65 mg/kg, i.v.). In vivo renal I/R was performed in both DM-II and normal rats. Lipid peroxidation, xanthine oxidase activity, and nitric oxide levels were significantly increased in cardiac tissue after I/R in diabetic rats compared to I/R in normal rats. Levels of antioxidant enzymes were significantly reduced after I/R in diabetic rats compared to normal rats. Serum TNF-α levels and cardiac tissue myeloperoxidase activity were also significantly increased after I/R in DM-II rats. In conclusion, DM-II rats showed exaggerated cardiac damage by renal I/R injury. Keywords : DIABETES TYPE-II, ISCHEMIA, REPERFUSION, HEART, INFLAMMATION, OXIDATIVE STRESS

Istanbul Medipol University